- NCIt
- C9479
Loading cancer entity…
Loading cancer entity…
Clinical trials
78 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07772869 | Uterine Lavage to Detect Ovarian Cancer Risk | recruiting | N/A | 75 | University of WashingtonOTHER | 1 | Sep 14, 2026 | clinicaltrials |
| NCT04471961 | Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia(ALADIN) | completed | N/A | 100 | University Hospital, MontpellierOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT06927947 | Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer Syndromes | recruiting | N/A | 625 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07307664 | Increasing Germline Genetic Testing for Patients With Cancer(gLHS) | recruiting | N/A | 1,000 | Josh PetersonOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT07618520 | Expanding Genetic Access for Prostate Cancer Survivors(ENGAGE) | not yet recruiting | N/A | 500 | Georgetown UniversityOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT04214210 | The DIALOGUE Study: Swiss-Korean Billateral Collaboration(DIALOGUE) | completed | N/A | 128 | University of BaselOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT04125914 | Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families | active not recruiting | N/A | 384 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT07416812 | Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations(IMPACT) | completed | N/A | 25 | Institute of Oncology LjubljanaOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT04623502 | An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy | recruiting | N/A | 600 | University of Texas Southwestern Medical CenterOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT05772130 | Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study | recruiting | N/A | 240 | City of Hope Medical CenterOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT07292246 | A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study)(ATHENA I) | recruiting | N/A | 15 | Vasileios KallesOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT01230346 | Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer | active not recruiting | N/A | 493 | City of Hope Medical CenterOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT06073626 | Addressing Genomic Disparities in Cancer Survivors | recruiting | N/A | 428 | Rutgers, The State University of New JerseyOTHER | 1 | Oct 28, 2025 | clinicaltrials |
| NCT03026998 | MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)(DepiSCARRH) | active not recruiting | N/A | 88 | Institut CurieOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT06284330 | CHARGE Study: CHoice ARchitecture Genetic tEsting(CHARGE) | completed | N/A | 108 | University of Texas Southwestern Medical CenterOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT06378749 | Previvors Recharge: A Resilience Program for Cancer Previvors(PreCharge) | completed | N/A | 138 | Pro-Change Behavior SystemsOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06767332 | EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial(FAME) | recruiting | N/A | 30 | Leiden University Medical CenterOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT04253106 | Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer(LISA-HDGC) | completed | N/A | 16 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT04197856 | Direct Information to At-risk Relatives(DIRECT) | unknown | N/A | 490 | Umeå UniversityOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT04242667 | Penn Biobank Return of Research Results Program | completed | N/A | 260 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT05805982 | Educational Video Versus In-person Genetic Counseling for Hereditary Cancer | completed | N/A | 251 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT05740111 | The PREPAIRD Study: Personalized Surveillance for Early Detection of Pancreatic Cancer in High Risk Individuals(PREPAIRD) | enrolling by invitation | N/A | 200 | Oslo University HospitalOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT03959267 | Testing a Culturally Adapted Telephone Genetic Counseling Intervention | completed | N/A | 37 | Georgetown UniversityOTHER | 1 | Sep 1, 2021 | clinicaltrials |
| NCT02381015 | Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a | completed | N/A | 700 | Endeavor HealthOTHER | 0 | Nov 22, 2019 | clinicaltrials |
| NCT03950908 | Biopsy Technique for Endoscopic Surveillance of Hereditary Diffuse Gastric Cancer | completed | N/A | 48 | University of CambridgeOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT00727532 | Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer | terminated | N/A | 9 | Northwestern UniversityOTHER | 1 | May 3, 2019 | clinicaltrials |
| NCT02557776 | Written Genetic Counseling and Mutation Analysis of BRCA1 and BRCA2 to Patients With Breast Cancer(BRCAsearch) | completed | N/A | 542 | Lund UniversityOTHER | 1 | Feb 6, 2019 | clinicaltrials |
Data updated 16 days agoSource updated Sep 14, 2026source: clinicaltrials